Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Bone Mineral Density At Diagnosis Determines Fracture Rate in Children Treated According to the DCOG-ALL9 Protocol

Mariel L te Winkel, MD, Rob Pieters, Prof, MD, PhD, Wim C.J. Hop, PhD, Jan C. Roos, Inge M. van der Sluis, MD, PhD, Jos P.M. Bökkerink, MD, PhD, Jan A. Leeuw, MD, Marrie C. A. Bruin, MD, PhD, Wouter J.W. Kollen, MD, PhD, Anjo J.P. Veerman, MD, PhD, Hester A. de Groot-Kruseman, PhD, Marry M. van den Heuvel-Eibrink

Blood (2012) 120 (21): 1469.

https://doi.org/10.1182/blood.V120.21.1469.1469

Published: 2012

Journal Articles

Unfavorable Prognostic Value of IKAROS but Not CRLF2 in Children with BCRABL1- positive Acute Lymphoblastic Leukemia,

Arian Van Der Veer, Marieke E. Willemse, Valerie De Haas, Anjo J.P. Veerman, Willem A. Kamps, Rob Pieters, Monique L. Den Boer

Blood (2011) 118 (21): 3528.

https://doi.org/10.1182/blood.V118.21.3528.3528

Published: 2011

Journal Articles

A Prospective Study on Incidence, Risk Factors and Long-Term Outcome of Osteonecrosis in 694 Patients with Pediatric Acute Lymphoblastic Leukemia,

Mariël L. te Winkel, MD, Rob Pieters, MD, PhD, Wim C.J. Hop, PhD, Hester A. de Groot-Kruseman, PhD, Maarten H. Lequin, MD, PhD, Inge M. van der Sluis, MD, PhD, Jos P.M. Bökkerink, MD, PhD, Jan A. Leeuw, MD, Marrie C. A. Bruin, MD, PhD, R. Maarten Egeler, MD, PhD, Anjo J.P. Veerman, MD, PhD, Marry M. van den Heuvel-Eibrink, MD, PhD

Blood (2011) 118 (21): 3578.

https://doi.org/10.1182/blood.V118.21.3578.3578

Published: 2011

Journal Articles

Pharmacokinetic and Pharmacodynamic Effects of PEG-Asparaginase in Newly Diagnosed Childhood Acute Lymphoblastic Leukemia: Results from a Single Agent Window Study.

Inge M. Appel, MD, Karin M. Kazemier, Anjo J.P. Veerman, MD, PhD, Elisabeth van Wering, PhD, Monique L. Den Boer, PhD, Rob Pieters, MD, PhD

Blood (2007) 110 (11): 860.

https://doi.org/10.1182/blood.V110.11.860.860

Published: 2007

Journal Articles

The Cryptic Chromosomal Deletion, del(11)(p12p13), as a New Activation Mechanism of LMO2 in Pediatric T-Cell Acute Lymphoblastic Leukemia.

Pieter Van Vlierberghe, Martine van Grotel, H. Berna Beverloo, Charles Lee, Tryggvi Helgason, Jessica Buijs-Gladdines, Monique Passier, Elisabeth R. van Wering, Anjo J.P. Veerman, Willem A. Kamps, Jules P.P. Meijerink, Rob Pieters

Blood (2006) 108 (11): 220.

https://doi.org/10.1182/blood.V108.11.220.220

Published: 2006

Journal Articles

Bone Mineral Density, Fracture Risk and Avascular Bone Necrosis in Childhood Acute Lymphoblastic Leukemia; an Up-Date of the Prospective DUTCH ALL9 Study.

Marry M. Van den Heuvel-Eibrink, MD, PhD, Inge M. Van der Sluis, MD, PhD, Bert A. Leeuw, MD, Gaby Kardos, MD, Lizet M. te Winkel, MD, Tom Revesz, MD, PhD, Elisabeth T. Korthof, MD, Jos Bokkerink, MD, PhD, Anjo J.P. Veerman, MD, PhD

Blood (2004) 104 (11): 1962.

https://doi.org/10.1182/blood.V104.11.1962.1962

Published: 2004

Journal Articles

Circumvention of Methotrexate Resistance in Childhood Leukemia Subtypes by Rationally Designed Antifolates

Marianne G. Rots, Rob Pieters, Godefridus J. Peters, Christina H. van Zantwijk, Rob Mauritz, Paul Noordhuis, James C. Willey, Karel Hählen, Ursula Creutzig, Gritta Janka-Schaub, Gertjan J.L. Kaspers, Anjo J.P. Veerman, Gerrit Jansen

Blood (1999) 94 (9): 3121–3128.

https://doi.org/10.1182/blood.V94.9.3121

Published: 1999

Journal Articles

Role of Folylpolyglutamate Synthetase and Folylpolyglutamate Hydrolase in Methotrexate Accumulation and Polyglutamylation in Childhood Leukemia

Marianne G. Rots, Rob Pieters, Godefridus J. Peters, Paul Noordhuis, Christina H. van Zantwijk, Gertjan J.L. Kaspers, Karel Hählen, Ursula Creutzig, Anjo J.P. Veerman, Gerrit Jansen

Blood (1999) 93 (5): 1677–1683.

https://doi.org/10.1182/blood.V93.5.1677

Published: 1999

Journal Articles

Differential Methotrexate Resistance in Childhood T- Versus Common/PreB-Acute Lymphoblastic Leukemia Can Be Measured by an In Situ Thymidylate Synthase Inhibition Assay, But Not by the MTT Assay

Marianne G. Rots, Rob Pieters, Gert-Jan L. Kaspers, Christina H. van Zantwijk, Paul Noordhuis, Rob Mauritz, Anjo J.P. Veerman, Gerrit Jansen, Godefridus J. Peters

Blood (1999) 93 (3): 1067–1074.

https://doi.org/10.1182/blood.V93.3.1067

Published: 1999

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Bone Mineral Density At Diagnosis Determines Fracture Rate in Children Treated According to the DCOG-ALL9 Protocol

Unfavorable Prognostic Value of IKAROS but Not CRLF2 in Children with BCRABL1- positive Acute Lymphoblastic Leukemia,

A Prospective Study on Incidence, Risk Factors and Long-Term Outcome of Osteonecrosis in 694 Patients with Pediatric Acute Lymphoblastic Leukemia,

Pharmacokinetic and Pharmacodynamic Effects of PEG-Asparaginase in Newly Diagnosed Childhood Acute Lymphoblastic Leukemia: Results from a Single Agent Window Study.

The Cryptic Chromosomal Deletion, del(11)(p12p13), as a New Activation Mechanism of LMO2 in Pediatric T-Cell Acute Lymphoblastic Leukemia.

Bone Mineral Density, Fracture Risk and Avascular Bone Necrosis in Childhood Acute Lymphoblastic Leukemia; an Up-Date of the Prospective DUTCH ALL9 Study.

Circumvention of Methotrexate Resistance in Childhood Leukemia Subtypes by Rationally Designed Antifolates

Role of Folylpolyglutamate Synthetase and Folylpolyglutamate Hydrolase in Methotrexate Accumulation and Polyglutamylation in Childhood Leukemia

Differential Methotrexate Resistance in Childhood T- Versus Common/PreB-Acute Lymphoblastic Leukemia Can Be Measured by an In Situ Thymidylate Synthase Inhibition Assay, But Not by the MTT Assay

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only